BG104257A - Дерматологични състави - Google Patents

Дерматологични състави

Info

Publication number
BG104257A
BG104257A BG104257A BG10425700A BG104257A BG 104257 A BG104257 A BG 104257A BG 104257 A BG104257 A BG 104257A BG 10425700 A BG10425700 A BG 10425700A BG 104257 A BG104257 A BG 104257A
Authority
BG
Bulgaria
Prior art keywords
nonbranching
branching chain
compositions
symptoms
carbon atoms
Prior art date
Application number
BG104257A
Other languages
English (en)
Inventor
Alain Fructus
Carine Bobier-Rival
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9510656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG104257(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of BG104257A publication Critical patent/BG104257A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Съставите се използват като лекарствено средство,по-специално при лечение на симптомите на кожна свръхчувствителност и псориазис, алергия, акне, стареене на кожата или за профилактика при симптоми на доброкачествено лятно обриване. Те включват ефективна комбинация от първи инхибитор на микробна пролиферация, представляващ водна смес на натриев полиакрилат, най-малко на един полиол и най-малко наедно гликолово съединение с формула: R1 - O - (R2 - O)nR3, в която R1 и R3 означават независимо един от друг Н или С1-С5 алкилова група с неразклонена или разклонена верига; R2 е С1-С5 алкиленова група с неразклонена или разклонена верига и n има стойност от 1 до 400 000, и втори инхибитор на микробна пролиферация, включващ най-малко един моноалкилглицеринов етер или естер с формула R4OCH2CH(OH)CH2OR5, в която R4 е алкилова група с неразклоненаили разклонена верига, съдържаща от 6 до 24 въглеродни атома, и R5 е Н или алканоилова група с неразклонена или разклонена верига, съдържаща от 8 до24 въглеродни атома. Изобретението се отнася също идо локално приложение на съставите.
BG104257A 1997-09-01 2000-03-20 Дерматологични състави BG104257A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9710866A FR2767697B1 (fr) 1997-09-01 1997-09-01 Composition dermatologique permettant d'eviter l'apparition de symptomes d'hypersensibilite et d'intolerance cutanee
PCT/EP1998/005704 WO1999011237A1 (en) 1997-09-01 1998-08-28 Dermatological compositions

Publications (1)

Publication Number Publication Date
BG104257A true BG104257A (bg) 2000-11-30

Family

ID=9510656

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104257A BG104257A (bg) 1997-09-01 2000-03-20 Дерматологични състави

Country Status (27)

Country Link
EP (1) EP0996418B2 (bg)
JP (1) JP4116243B2 (bg)
KR (1) KR20010023533A (bg)
CN (1) CN1272783A (bg)
AR (1) AR013459A1 (bg)
AT (1) ATE266383T1 (bg)
AU (1) AU738015B2 (bg)
BG (1) BG104257A (bg)
BR (1) BR9812427A (bg)
CA (1) CA2301616C (bg)
CZ (1) CZ299379B6 (bg)
DE (1) DE69823830D1 (bg)
ES (1) ES2221207T5 (bg)
FR (1) FR2767697B1 (bg)
HU (1) HUP0003424A3 (bg)
ID (1) ID25508A (bg)
IL (1) IL134806A0 (bg)
NO (1) NO20001014L (bg)
NZ (1) NZ502645A (bg)
PL (1) PL199392B1 (bg)
PT (1) PT996418E (bg)
RU (1) RU2195926C2 (bg)
SK (1) SK284710B6 (bg)
TR (1) TR200000560T2 (bg)
TW (1) TW516968B (bg)
WO (1) WO1999011237A1 (bg)
ZA (1) ZA987902B (bg)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022952A1 (es) 1999-03-19 2002-09-04 Smithkline Beecham Corp ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
DE10028638A1 (de) 2000-06-09 2001-12-20 Schuelke & Mayr Gmbh Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern
ES2208498T3 (es) * 2001-06-22 2004-06-16 SYMRISE GMBH & CO. KG Uso de 1,2-decanodiol contra germenes causantes de olores corporales desagradables.
DE10206759A1 (de) 2002-02-19 2003-08-28 Dragoco Gerberding Co Ag Synergistische Mischungen von 1,2-Alkandiolen
FR2850040B1 (fr) * 2003-01-20 2005-03-11 Centre Nat Rech Scient Systemes pour microencapsulation et leurs applications
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US9826770B2 (en) 2005-03-10 2017-11-28 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxycarboxylic acids
CN101175474B (zh) 2005-03-10 2011-09-07 3M创新有限公司 降低微生物污染的方法
US8147875B2 (en) * 2005-03-15 2012-04-03 Campina Nederland Holding B.V. Dermatologic use of milk proteins
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
KR101450681B1 (ko) * 2006-12-22 2014-10-14 가부시키가이샤 니폰 배리어 프리 화장료
US9011943B2 (en) 2007-02-16 2015-04-21 Skin Evolution LLC Compositions and methods for alleviating skin disorders
US7488500B2 (en) 2007-02-16 2009-02-10 Betty Bellman Compositions and methods for alleviating skin disorders
WO2008101239A1 (en) * 2007-02-16 2008-08-21 Betty Bellman Compositions and methods for alleviating skin disorders
US7758901B2 (en) 2007-02-16 2010-07-20 Betty Bellman Compositions and methods for alleviating skin disorders
DE102007017851A1 (de) * 2007-04-16 2008-10-23 Schülke & Mayr GmbH Zusammensetzung auf Basis von Glycerinether/Polyol-Gemischen
CN101687106B (zh) * 2007-06-01 2015-04-29 盖尔德马研究及发展公司 新型保湿剂及其用途
EP2224973B1 (en) * 2007-11-29 2016-04-20 Inolex Investment Corporation Preservatives for cosmetic, toiletry and pharmaceutical compositions
US8691248B2 (en) 2008-03-11 2014-04-08 Mary Kay Inc. Stable three-phased emulsions
JP5041551B2 (ja) * 2009-09-25 2012-10-03 株式会社 資生堂 油中水型乳化皮膚化粧料
DE102011109868A1 (de) * 2011-08-10 2013-02-14 STERNA BIOLOGICALS GmbH & Co. KG. Multiple Emulsion
RU2468786C1 (ru) * 2011-12-12 2012-12-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") Гель для ухода за кожей вокруг глаз
KR101830599B1 (ko) * 2013-05-01 2018-02-22 더 프록터 앤드 갬블 캄파니 멜라닌 합성을 억제하기 위한 화장 조성물 및 방법
ES2667679T3 (es) * 2013-07-04 2018-05-14 L'oréal Composición cosmética que comprende un cuerpo graso pastoso y un derivado no iónico de celulosa modificado hidrófobo
WO2017218783A1 (en) * 2016-06-17 2017-12-21 Benchmark Cosmetic Laboratories, Inc. Sphere forming compositions
CN106860229A (zh) * 2017-01-18 2017-06-20 长沙协浩吉生物工程有限公司 一种酵素抗过敏日霜的配制方法
CN108125896A (zh) * 2018-01-12 2018-06-08 广州赛莱拉干细胞科技股份有限公司 基于鲨肝醇硬脂酸酯的洗手液
CN108403615A (zh) * 2018-04-10 2018-08-17 广州赛莱拉干细胞科技股份有限公司 包括鲨肝醇异硬脂酸酯的组合物及其在化妆品的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2831030B2 (ja) * 1989-05-12 1998-12-02 学校法人城西大学 ３’‐アジド‐３’デオキシチミジンを有効成分とする経皮投与製剤用組成物
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
FR2679563B1 (fr) * 1991-07-22 1995-06-09 Agro Ind Recherc Dev Alkylgalactosides uronates d'alkyle, leur procede de preparation et leurs applications, notamment comme agents tensio-actifs non ioniques.
FR2679444B1 (fr) * 1991-07-25 1995-04-07 Oreal Utilisation comme agents epaississants des huiles, dans une composition cosmetique huileuse, d'une association de deux copolymeres.
FR2682296B1 (fr) * 1991-10-14 1993-11-12 Sederma Sa Nouvelles compositions cosmetiques contenant des gels polymeriques.
DE4140474C2 (de) * 1991-12-09 1995-07-13 Schuelke & Mayr Gmbh Hautpflegeadditiv
DE4240674C2 (de) * 1992-11-26 1999-06-24 Schuelke & Mayr Gmbh Desodorierende Wirkstoffe
DE4420625C1 (de) * 1994-06-14 1995-11-02 Beiersdorf Ag Wirkstoffkombination mit einem Gehalt an Glycerylalkylethern und kosmetische und dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend
FR2729050A1 (fr) * 1995-02-23 1996-07-12 Oreal Compositions resistant a la degradation microbienne
FR2734158B1 (fr) * 1995-05-17 1997-06-27 Roche Posay Lab Pharma Association d'un compose a activite anti-microbienne et d'un monoalkylether de glycerol
FR2737406B1 (fr) * 1995-08-04 1997-10-24 Sederma Sa Gel a activite physique pour produits cosmetiques
DE19538555A1 (de) * 1995-10-17 1997-04-24 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen
AU6704396A (en) * 1996-07-19 1998-02-10 Sederma Sa Compositions for treating sunburn and oral hygiene problems

Also Published As

Publication number Publication date
CN1272783A (zh) 2000-11-08
NO20001014D0 (no) 2000-02-29
FR2767697A1 (fr) 1999-03-05
AU9623798A (en) 1999-03-22
PL341686A1 (en) 2001-04-23
NZ502645A (en) 2002-06-28
CA2301616C (en) 2010-03-09
EP0996418B2 (en) 2009-04-08
EP0996418A1 (en) 2000-05-03
SK284710B6 (sk) 2005-09-08
CZ299379B6 (cs) 2008-07-09
KR20010023533A (ko) 2001-03-26
CZ2000732A3 (cs) 2000-06-14
NO20001014L (no) 2000-02-29
ID25508A (id) 2000-10-05
ZA987902B (en) 1999-03-01
IL134806A0 (en) 2001-04-30
DE69823830D1 (de) 2004-06-17
ES2221207T5 (es) 2009-06-15
ES2221207T3 (es) 2004-12-16
JP4116243B2 (ja) 2008-07-09
JP2001514205A (ja) 2001-09-11
FR2767697B1 (fr) 2000-05-05
AU738015B2 (en) 2001-09-06
PL199392B1 (pl) 2008-09-30
SK2702000A3 (en) 2000-08-14
HUP0003424A2 (hu) 2001-02-28
BR9812427A (pt) 2000-09-19
TW516968B (en) 2003-01-11
ATE266383T1 (de) 2004-05-15
AR013459A1 (es) 2000-12-27
PT996418E (pt) 2004-09-30
WO1999011237A1 (en) 1999-03-11
RU2195926C2 (ru) 2003-01-10
CA2301616A1 (en) 1999-03-11
TR200000560T2 (tr) 2002-06-21
WO1999011237A9 (en) 2000-04-06
HUP0003424A3 (en) 2003-04-28
EP0996418B1 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
BG104257A (bg) Дерматологични състави
YU2997A (sh) Derivati triazola korisni u terapiji
LV12618A (en) Use of sulphamate derivatives as steroid sulphatase inhibitors
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
HK1011685A1 (en) Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
ES2128552T3 (es) Combinacion de un inhibidor de la biosintesis del colesterol y un inhibidor de la absorcion del colesterol beta-lactama.
HK1034911A1 (en) Novel fatty acid analogues for the treatment of secondary restenosis
BG102425A (bg) (метилсулфонил)фенил-2-(5н)-фуранони като инхибитори на циклооксигеназа-2
AR004701A1 (es) 2-azetidinonas substituidas con azucares utiles como agentes hipocolesterolemicos, composicion farmaceutica, proceso para la preparacion dedicha composicion, uso de dichos compuestos para fabricar medicamentos y un equipo.
PL311294A1 (en) Improved, pharmaceutically admissible composition containing alcohol and a hydrophobous drug
MY106067A (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors.
MY115339A (en) Compositions containing micronized nebivolol
BG103656A (bg) Флуороетерни състави и методи за инхибиране на тяхното разпадане в присъствие на люисова киселина
TW200501995A (en) Treatment for skin
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
ES2077549T1 (es) Composiciones dermatologicas que contienen derivados de estilbeno para la proteccion frente a la radiacion uv.
HK1022298A1 (en) Vitamin d analogues
ES2180751T3 (es) Inhibidor de metastasis de cancer.
IL108856A0 (en) Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
JPS6413018A (en) Skin-beautifying cosmetic
MY104998A (en) Detergent composition
AU2953697A (en) Vitamin d analogs and methods of preparing these compounds
AR016733A1 (es) Procedimiento de preparacion de 4-(3-piridinil)-1h-imidazol, y los compuestos intermedios empleados
NZ323980A (en) Antiseptic composition containing a quaternary ammonium compound, a chelating agent and a polyol